Navigation Links
Substance Abuse Treatment Pipeline Dominated by Nicotine and Alcohol Addiction Treatments, Says GBI Research
Date:3/29/2016

LONDON, March 29, 2016 /PRNewswire/ --

A new report from business intelligence provider GBI Research - Substance Abuse Deterrents and Treatments: An Assessment of the Technological, Competitive and R&D Landscape - the substance abuse treatment pipeline is dominated by therapies for nicotine and addiction, with the 34 and 32 products in respective active development combining to produce over 50% of the total pipeline. Despite this, there are several promising candidates in development targeting a range of other indications including opioid and cocaine addiction.

Various new approaches currently under investigation will see novel and first-in-class treatments, including vaccines, redefine the current arena.

A growing treatment pipeline and continued research and investment in this field reflect the fact that current therapies for those suffering from various drug addictions remain insufficient.  More than 27 million people worldwide are currently classified as problem drug users under the Nations Office on Drugs and Crime's guidelines. Of these, only one in six has access to therapy while many countries still have no adequate services for treating substance abuse.

Managing Analyst Rodrigo Gutierrez Gamboa says: "One of the main reasons why substance abuse remains high and is so difficult to treat is that there is not yet a complete understanding of the various aspects encompassing this global issue.

"Several molecular targets have been identified and have furthered drug development, but there are various other targets that are not clearly understood. The poor understanding of the brain mechanisms of addiction represents a significant challenge in terms of developing a highly effective drug, or combination drugs, for treating addiction."

GBI Research states that there are 242 companies marketing therapies for substance abuse, and more of these are involved in marketing treatments for alcohol addiction than any other kind. One in every 12 adults suffers from alcohol abuse or dependence in the US, which illustrates the level of demand for these therapies.

Gutierrez Gamboa continues: "The competitive landscape is comprised of both large pharmaceutical companies and specialized companies focusing solely on developing substance abuse treatments, with the top eight companies comprising Teva, Allergan, Mylan, Sun Pharma, Sanofi, Psyco Remedies, Rusan Pharma, and Aspen Pharmacare.

"Despite the current market focused so heavily on alcohol abuse, there are significant numbers of products in development for the treatment of other addictions and associated withdrawal syndromes. Emerging product segments include cocaine and opioid addictions, with 26 and 21 pipeline drugs, respectively, while the cannabinoids and methamphetamine treatment segments also have several promising drugs in active development."

Sample pages of GBI Research's report Substance Abuse Deterrents and Treatments: An Assessment of the Technological, Competitive and R&D Landscape are available upon request

About GBI Research 

GBI Research is a leading provider of business intelligence reports, offering actionable data and forecasts based on the insights of key healthcare industry influencers to ensure you stay up-to-date with the latest market trends.

Connect with GBI Research on social media for the latest healthcare market updates:

Facebook | LinkedIn | Twitter


'/>"/>
SOURCE GBI Research
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. New Survey: Hispanic Teen Drug Use Significantly Higher Than Other Ethnic Groups, Substance Abuse Becoming Normalized Behavior Among Latino Youth
2. Consumer Watchdog Calls On Kaiser CEO To Disclose Substance Abuse & Patient Safety Problems At Health System Following High Profile Denials By Kaiser Doc
3. Germany Decides: E-Cigarettes Are Not Pharmaceutical Substances
4. Evotec Adopts ChemAxons Compliance Checker to Aid Controlled Substance Management
5. H. D. Smith named finalist for HDMAs Distribution Management Award for innovative mobile controlled substance ordering system
6. NABP, Stakeholders Release Consensus Document on the Challenges and "Red Flag" Warning Signs Related to Prescribing and Dispensing Controlled Substances
7. Elektas MOSAIQ Oncology Information System now offers ePrescribing of controlled substances
8. Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S.
9. Aptuit Announces Expansion of Integrated CMC Offering (Drug Substance and Drug Product) to Phase 3 and Commercial Scale
10. Substance Abuse Professionals to Share Latest Ways to Treat Addiction
11. A Significant Number of Adults Cant Identify Signs of Substance Abuse in Seniors; According to a New National Survey by Harris Poll on behalf of Caron Treatment Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2019)... ... 2019 , ... In this month’s NEPC Education Interview ... A. Smith speaks with Christopher Saldaña, Doctoral Student Researcher at the National Education ... in the marketing of educational resources to schools. , Along with his co-authors, ...
(Date:2/14/2019)... ... February 14, 2019 , ... ... focuses on developing and commercializing minimally-invasive, innovative spinal technologies, today announced a ... Surgical name better emphasizes our commitment to delivering new, cutting-edge, surgical solutions ...
(Date:2/13/2019)... ... 2019 , ... Entomol’s breakthrough safe and effective all natural ... release and sale within the state. California has the most stringent regulatory approval ... This registration opens the door for wholesale/retail and military sales opportunities within the ...
Breaking Medicine Technology:
(Date:2/13/2019)... ... February 13, 2019 , ... Dr. Jig Patel and ... Muizz Merchant, an exceptionally talented and knowledgeable dentist from St. Louis, MO, ... dental techniques, such as CEREC same-day dentistry, root canals and emergency treatment. Dr. Patel, ...
(Date:2/13/2019)... (PRWEB) , ... February 13, 2019 , ... Surgery that ... effective and safe treatment for obstructive sleep apnea (OSA), resulting in benefits that include ... risk, according to a new study. , MMA should be regarded as the preferred ...
(Date:2/13/2019)... BEACH GARDENS, Fla. (PRWEB) , ... February 13, ... ... their exclusivity, and luxurious lifestyle publication is privileged to present Dr. David A. ... Living partnership. , Haute Beauty offers a prominent collective of leading doctors. The ...
(Date:2/12/2019)... , ... February 12, 2019 , ... ... interactive workshop from FDAnews and Ombu Enterprises**, Feb. 19-20, 2019, Atlanta, GA , ... Management: Prepare for the Winds of Change on Jan. 22 , Risk management ...
(Date:2/12/2019)... ... February 12, 2019 , ... Accreditation Commission ... Island Partnership for Home Care. This agreement allows Rhode Island Partnership for Home ... Duty Accreditation services, as well as discounts on ACHCU educational resources that help ...
Breaking Medicine News(10 mins):